Pharma R&D rebounds in 2015 after hitting all-time low in 2014: PMPRB data
A 9.7% uptick in Canadian pharmaceutical R&D in 2015 raised the sector's R&D-to-sales ratio 0.1% to 4.4%. That's nowhere near the eight-year run of more than 10% between 1993 and 2000 but an encouraging sign that the long, slow decline of recent years may be at an end.
Other stories mentioning these organizations, people and topics
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 0 free articles remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.